Abstract QS37: Induction Of Delayed Immune Tolerance After Reconstructive Transplantation By Combining Donor Bone Marrow Transplantation And High-dose Cyclophosphamide Treatment

Documenti analoghi

• Abstract QS24: Preoperative Opioids and Panniculectomy Outcomes
  di: Cheah, Michael A., et al.
  Pubblicazione: (2019)
• Abstract 3: Ex Vivo Expanded Regulatory T Cells Combined With Short-term Costimulation Blockade Prevent Rejection Of Vascularized Composite Allografts
  di: Grzelak, Michael, et al.
  Pubblicazione: (2019)
• Abstract 38: Ex Vivo Expanded Regulatory T Cells Combined With Short-term Costimulation Blockade To Prevent Rejection Of Vascularized Composite Allografts
  di: Grzelak, Michael J., et al.
  Pubblicazione: (2018)
• Abstract QS22: A Novel And Unexpected Role Of Donor T Cells In The Efficacy Of Tolerogenic Therapies For Transplant Rejection
  di: Lozano, Marcos Iglesias, et al.
  Pubblicazione: (2019)
• Abstract 44: Tolerance Induction with Post Transplantation High-Dose Cyclophosphamide relies on Recipient-derived Immune Regulation and Donor Bone Marrow in a Murine Model of Vascularized Composite Allotransplantation
  di: Furtmüller, Georg J., et al.
  Pubblicazione: (2017)